SCHEMBL623292

SCHEMBL623292

CC(F)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030843 1.00
SCHEMBL1033082 1.00
SCHEMBL1028572 0.72
SCHEMBL1028075 0.72
SCHEMBL6663608 0.72
SCHEMBL19508366 0.72
Isobutyraldehyde SCHEMBL2635854 0.70 ADH1B (0.38)
SCHEMBL74788 0.70
Isobutyraldehyde SCHEMBL2996 0.70
Isobutyraldehyde SCHEMBL788159 0.70 ADH1B (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829516-B2 Peptidomimetics for imaging the ghrelin receptor LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2020-11-10 US claimed
EP-3033343-B1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK NOVARTIS AG (CH) 2018-12-05 EP claimed
EP-2763987-B1 HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE AS FUNGICIDALS BAYER CROPSCIENCE AG (DE) 2018-07-18 EP claimed
US-20170183348-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2017-06-29 US claimed
EP-2763993-B1 HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE BAYER IP GMBH (DE) 2017-04-19 EP claimed
EP-3033343-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK Novartis AG (CH) 2016-06-22 EP claimed
US-20160136150-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK NOVARTIS AG (CH) 2016-05-19 US claimed
WO-2016016446-A1 PROCESS FOR PREPARING 2-FLUOROPROPIONALDEHYDE SANDOZ AG (CH) 2016-02-04 WO claimed
US-9227969-B2 Compounds and compositions as inhibitors of MEK NOVARTIS AG (CH) 2016-01-05 US claimed
US-9023844-B2 Heterocyclylpyri (mi) dinylpyrazole as fungicidals BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-05-05 US claimed
EP-2763987-A1 HETEROCYCLYLPYRI (MI) DINYLPYRAZOLE AS FUNGICIDALS Bayer Intellectual Property GmbH (DE) 2014-08-13 EP claimed
EP-2763993-A1 HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE Bayer Intellectual Property GmbH (DE) 2014-08-13 EP claimed
CN-102482287-B 3-heteroarylmethyl-imidazo [1,2-B ] pyridazin-6-yl derivatives as modulators of C-Met tyrosine kinase NOVARTIS AG 2014-07-23 CN claimed
US-8710098-B2 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Chinese Academy of Medical Science (CN) 2014-04-29 US claimed
CN-101535276-B 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC 2013-08-28 CN claimed
WO-2013050434-A1 HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-04-11 WO claimed
WO-2013050437-A1 HETEROCYCLYLPYRI (MI) DINYLPYRAZOLE AS FUNGICIDALS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-04-11 WO claimed
US-8119609-B2 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants MERCK SANTE (FR) 2012-02-21 US claimed
US-20030216290-A1 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors MERCK SANTE, A CORPORATION OF FRANCE (FR) 2003-11-20 US claimed
US-5462705-A Method of forming diffusely reflecting sintered fluorinated long-chain addition polymers doped with pigments for color standard use LABSPHERE, INC. (US) 1995-10-31 US claimed